The role of renal adenosine 3',5'-monophosphate in the control of erythropoietin production
- PMID: 163577
- DOI: 10.1016/0002-9343(75)90530-6
The role of renal adenosine 3',5'-monophosphate in the control of erythropoietin production
Abstract
A regulatory role for adenosine 3',5'-monophosphate (cyclic AMP) in the production of the renal hormone rythropoietin following erythropoietic stimulation with cobaltous chloride hexahydrate is proposed. Studies in rates reveal a temporal relationship between renal cyclic AMP levels and plasma titers of erythropoietin. In addition, cobalt increases the activity of an erythropoietin-generating enzyme (renal erythropoietic factor) with maximal enzyme activity occurring after the rise in cyclic AMP levels but before the increase in erythropoietin titers. This increase in renal cyclic AMP is localized to the renal cortex. Cobalt stimulates renal cortical adenylate cyclase but has no effect on renal cyclic nucleotide phosphodiesterase. The addition of cyclic AMP (3 time 10-6 M) and a partially purified cyclic AMP-dependent protein kinase from rat kidney to an inactive preparation of renal erythropoietic factor increases the ability of renal erythropoietic factor to generate erythropoietin. Data from the polycythemic mouse assay, a bioassay used to quantitate erythropoietic activity of test substances, indicate that dibutyryl cyclic AMP is erythropoietically active with respect to its ability to increase radioactive-labelled iron (59Fe) incorporation into heme of newly formed red blood cells. Theophylline, which by itself is erythropoietically inactive, potentiated the erythropoietic effect of cobalt in polycythemic mice. These results suggest that cyclic AMP plays a significant role in the renal production of erythropoietin following cobalt administration. It is postulated that cobalt stimulates renal cortical adenyoate cyclase, thus increasing renal cyclic AMP levels. Cyclic AMP then activates a protein kinase which subsequently stimulates renal erythropoietic factor to generate erythropoietin. A similar cyclic AMP mechanism may be operative after erythropoietic stimulation by exposure to hypoxia or prostaglandin treatment.
Similar articles
-
Renal cyclic AMP accumulation and adenulate cyclase stimulation by erythropoietic agents.Am J Physiol. 1975 Nov;229(5):1387-92. doi: 10.1152/ajplegacy.1975.229.5.1387. Am J Physiol. 1975. PMID: 173193
-
Lactate stimulation of renal cortical adenylate cyclase: a mechanism for erythropoietin production following cobalt treatment or hypoxia.J Pharmacol Exp Ther. 1974 Sep;190(3):542-50. J Pharmacol Exp Ther. 1974. PMID: 4370141 No abstract available.
-
Adenosine, AMP, cyclic AMP, theophylline and the action and production of erythropoietin.Proc Soc Exp Biol Med. 1975 Oct;150(1):215-9. doi: 10.3181/00379727-150-39005. Proc Soc Exp Biol Med. 1975. PMID: 171682
-
The role of hypoxia in renal production of erythropoietin.Cancer. 1992 Aug 15;70(4 Suppl):928-39. Cancer. 1992. PMID: 1638465 Review.
-
Prostaglandins and kidney erythropoietin production.Nephron. 1980;25(2):53-6. doi: 10.1159/000181753. Nephron. 1980. PMID: 6243754 Review. No abstract available.
Cited by
-
Adenosine in exercise adaptation.Br J Sports Med. 1992 Mar;26(1):54-8. doi: 10.1136/bjsm.26.1.54. Br J Sports Med. 1992. PMID: 1600457 Free PMC article. Review.
-
Adenosine and the adaptation to exercise.Sports Med. 1993 Apr;15(4):219-24. doi: 10.2165/00007256-199315040-00001. Sports Med. 1993. PMID: 8460286 Review. No abstract available.
-
Erythrocytic system under the influence of physical exercise and training.Sports Med. 1990 Sep;10(3):181-97. doi: 10.2165/00007256-199010030-00004. Sports Med. 1990. PMID: 2237034 Review.
-
A novel experimental hypoxia chamber for cell culture.Am J Cancer Res. 2014 Jan 15;4(1):53-60. eCollection 2014. Am J Cancer Res. 2014. PMID: 24482738 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources